The Cooper Companies Inc (Cooper) is a medical device company primarily catering to the fertility and vision care markets.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.

Cooper emphasizes addressing the ongoing issues and untapped areas in the eyecare and fertility markets. It focuses on developing new contact lens designs, myopia management, and manufacturing technologies through CooperVision, and innovating instruments, devices, consumables, digital services, and manufacturing technologies through CooperSurgical. The company also aims to improve formulations and existing products. The R&D units of the company are CooperVision and CooperSurgical. CooperVision is responsible for product development and clinical research in areas such as lens design, formulation science, polymer chemistry, engineering, clinical trials, microbiology, and biochemistry. CooperSurgical conducts research and development in mechanical, electrical, biomedical, and software engineering, as well as life sciences, focusing on diagnostic and therapeutic products, including medical interventions, surgical devices, and fertility solutions. In FY2025, the company spent US$172.2 million on its R&D activities, which as a percentage of revenue stood at 4.2%, and grew 11% YoY.